Literature DB >> 15592497

Altered expression of cell cycle genes distinguishes aggressive neuroblastoma.

Alexei L Krasnoselsky1, Craig C Whiteford, Jun S Wei, Sven Bilke, Frank Westermann, Qing-Rong Chen, Javed Khan.   

Abstract

In this study, gene expression profiling was performed on 103 neuroblastoma (NB) tumors, stages 1-4 with and without MYCN amplification, using cDNA microarrays containing 42,578 elements. Using principal component analysis (PCA) to analyse the relationships among these samples, we confirm that the global patterns of gene expression reflect the phenotype of the tumors. To explore the biological processes that may contribute to increasing aggressive phenotype of the tumors, we utilized a statistical approach based on PCA. We identified a specific subset of the cell cycle and/or chromosome segregation genes that distinguish stage 4 NB tumors from all lower stage tumors, including stage 3. Furthermore, the control of the kinetochore assembly emerges from the Gene Ontology analysis as one of the key biological processes associated with an aggressive NB phenotype. Finally, we establish that these genes are further upregulated in the most aggressive MYCN-amplified tumors.

Entities:  

Mesh:

Year:  2005        PMID: 15592497     DOI: 10.1038/sj.onc.1208341

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.

Authors:  Ronan S Rogers; Moyez Dharsee; Suzanne Ackloo; Jeremy M Sivak; John G Flanagan
Journal:  Mol Cell Proteomics       Date:  2011-11-29       Impact factor: 5.911

2.  MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.

Authors:  Russell Moser; Masafumi Toyoshima; Kristin Robinson; Kay E Gurley; Heather L Howie; Jerry Davison; Martin Morgan; Christopher J Kemp; Carla Grandori
Journal:  Mol Cancer Res       Date:  2012-02-01       Impact factor: 5.852

3.  EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.

Authors:  Chunxi Wang; Zhihui Liu; Chan-Wook Woo; Zhijie Li; Lifeng Wang; Jun S Wei; Victor E Marquez; Susan E Bates; Qihuang Jin; Javed Khan; Kai Ge; Carol J Thiele
Journal:  Cancer Res       Date:  2011-11-08       Impact factor: 12.701

4.  Upregulation of FAM83D promotes malignant phenotypes of lung adenocarcinoma by regulating cell cycle.

Authors:  Run Shi; Jing Sun; Qi Sun; Quanli Zhang; Wenjie Xia; Gaochao Dong; Anpeng Wang; Feng Jiang; Lin Xu
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

5.  Database of mRNA gene expression profiles of multiple human organs.

Authors:  Chang Gue Son; Sven Bilke; Sean Davis; Braden T Greer; Jun S Wei; Craig C Whiteford; Qing-Rong Chen; Nicola Cenacchi; Javed Khan
Journal:  Genome Res       Date:  2005-03       Impact factor: 9.043

6.  Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.

Authors:  Julieann Rader; Mike R Russell; Lori S Hart; Michael S Nakazawa; Lili T Belcastro; Daniel Martinez; Yimei Li; Erica L Carpenter; Edward F Attiyeh; Sharon J Diskin; Sunkyu Kim; Sudha Parasuraman; Giordano Caponigro; Robert W Schnepp; Andrew C Wood; Bruce Pawel; Kristina A Cole; John M Maris
Journal:  Clin Cancer Res       Date:  2013-09-17       Impact factor: 12.531

7.  microRNA profiling identifies cancer-specific and prognostic signatures in pediatric malignancies.

Authors:  Jun S Wei; Peter Johansson; Qing-Rong Chen; Young K Song; Steffen Durinck; Xinyu Wen; Adam T C Cheuk; Malcolm A Smith; Peter Houghton; Christopher Morton; Javed Khan
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

Review 8.  Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.

Authors:  Kristopher R Bosse; John M Maris
Journal:  Cancer       Date:  2015-11-05       Impact factor: 6.860

Review 9.  Epigenetic changes in pediatric solid tumors: promising new targets.

Authors:  Elizabeth R Lawlor; Carol J Thiele
Journal:  Clin Cancer Res       Date:  2012-05-15       Impact factor: 12.531

10.  Slow proliferation as a biological feature of colorectal cancer metastasis.

Authors:  A Anjomshoaa; S Nasri; B Humar; J L McCall; A Chatterjee; H-S Yoon; L McNoe; M A Black; A E Reeve
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.